CELL INTELLIGENCE · 肿瘤细胞治疗研究

CAR-T 细胞治疗前基于苯达莫司汀的淋巴细胞清除：一项系统综述

Bendamustine-based lymphodepletion prior to CAR T-cell therapy: a systematic review.

多发性骨髓瘤的治疗前沿：临床试验新兴格局分析

Therapeutic Horizon in Multiple Myeloma: Analysis of the Emerging Landscape of Clinical Trials.

多发性骨髓瘤临床试验的增加凸显了向生物治疗的转变，尤其是免疫治疗和 CAR-T 等基因治疗。

接受抗 BCMA CAR-T 细胞治疗的多发性骨髓瘤患者的病毒再激活

Viral Reactivation in Multiple Myeloma Patients Receiving Anti-BCMA Chimeric Antigen Receptor T-Cell Therapy.

超越 CAR-T：CAR-NK/T 细胞在血液肿瘤中的兴起

Beyond CAR-T: The Rise of CAR-NK/T Cells for Haematological Cancer.

CAR-NK/T 细胞可能被证明是治疗血液系统恶性肿瘤的一种更安全、更灵活的细胞疗法。

多发性骨髓瘤 CAR 治疗的靶点

Targets for CAR Therapy in Multiple Myeloma.

靶向多发性骨髓瘤的抗 BCMA CAR 的临床前评价与结构优化

Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myeloma.